dual PI3K-alpha/mTOR inhibitors (Exelixis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual PI3K-alpha/mTOR inhibitors (Exelixis)
Drug Alias NameEXEL-4251EXEL-1229EXEL-3751EXEL-2400
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsAnticancer protein kinase inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsPhosphatidylinositol 3 kinase alphaSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A